Chris McCabe
Has grant
Global Asset Medical Community Head
BelgiumResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Chris McCabe is the Global Asset Medical Community Head at UCB Pharma in Belgium. His research focuses on vascular cognitive impairment, cerebrospinal fluid dynamics, and the impact of stroke co-morbidities. Recent publications include articles on pre-clinical assessment outcomes for vascular cognitive impairment, as well as studies investigating the mechanisms behind increased intracranial pressure following ischaemic stroke.
Recent Grants
Grant: Close
Memantine – developing a prophylactic treatment for ischemic stroke
Open Date: 2016-03-01
Close Date: 2018-03-01
Grant: Close
Brain damage after stroke: role of Angiotensin-1-7.
Open Date: 2014-10-01
Close Date: 2016-09-01
Grant: Close
Supporting the ischaemic brain with oxygen-carrying perfluorocarbons.
Open Date: 2011-01-01
Close Date: 2013-01-01
Grant: Close
Inhibition of NADPH Oxidase as a potential neuroprotective strategy in the Stroke Prone Spontaneously Hypertensive (SHRSP) rat.
Open Date: 2010-01-01
Close Date: 2011-01-01
Grant: Close
Metabolic syndrome, acute hyperglycemia and ischaemic lesion growth after experimentally-induced stroke.
Open Date: 2009-01-01
Close Date: 2010-01-01
Articles (4)
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (5)
Hilary Carswell
University Of Strathclyde
Lorraine Work
Reader
University of Glasgow
Rebecca Trueman
Associate Professor
University of Nottingham
J Scott Miners
University of Bristol
Tracy D Farr
Associate Professor
University of Nottingham
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.